Essbio (XSGO:ESSBIO-C) Other Current Receivables: CLP4,022 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSGO:ESSBIO-C Essbio SA XSGO:ESSBIO-C
60 GF Score
Price CLP9.99
GF Value CLP13.64
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Essbio Other Current Receivables?

Essbio XSGO:ESSBIO-C 60 Other Current Receivables is CLP4,022 Mil as of Mar. 2026. GuruFocus rates XSGO:ESSBIO-C with a GF Score™ of 60/100 and a GF Value™ of CLP13.64 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Essbio's Other Current Receivables for the quarter that ended in Mar. 2026 was CLP4,022 Mil.

Essbio's quarterly Other Current Receivables declined from Sep. 2025 (CLP4,323.31 Mil) to Dec. 2025 (CLP3,604.54 Mil) but then increased from Dec. 2025 (CLP3,604.54 Mil) to Mar. 2026 (CLP4,022.34 Mil).

Essbio's annual Other Current Receivables increased from Dec. 2023 (CLP3,809.89 Mil) to Dec. 2024 (CLP3,985.13 Mil) but then declined from Dec. 2024 (CLP3,985.13 Mil) to Dec. 2025 (CLP3,604.54 Mil).

Essbio Other Current Receivables Related Terms

Essbio Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Essbio's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Essbio Other Current Receivables Chart

Essbio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,656.56 3,563.95 3,809.89 3,985.13 3,604.54

Essbio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,292.40 4,487.06 4,323.31 3,604.54 4,022.34
XSGO:ESSBIO-C
60GF Score
Essbio SA XSGO:ESSBIO-C
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Essbio Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of CLP4,022 Mil mean?
Essbio (XSGO:ESSBIO-C) has a Other Current Receivables of CLP4,022 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Essbio and its competitors.
Is Essbio's Other Current Receivables too high?
Essbio's current Other Current Receivables is CLP4,022 Mil. Overall, Essbio has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Essbio's Other Current Receivables compare to AWK and WTRG?
Essbio's Other Current Receivables of CLP4,022 Mil can be compared against companies in the Utilities - Regulated industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for an Utilities - Regulated company?
A good Other Current Receivables depends on the Utilities - Regulated industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Essbio and its competitors. Essbio's current Other Current Receivables is CLP4,022 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Essbio stock overvalued right now?
Based on GuruFocus' analysis, Essbio (XSGO:ESSBIO-C) is currently considered Modestly Undervalued. The stock's GF Value™ is CLP13.64, compared to a current price of CLP9.99 — trading 26.8% below its estimated fair value. The current Other Current Receivables is CLP4,022 Mil. Essbio's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Essbio (XSGO:ESSBIO-C), the current Other Current Receivables is CLP4,022 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Essbio (XSGO:ESSBIO-C) Overvalued in 2026?

Based on GuruFocus' analysis, Essbio stock appears to be undervalued. The current stock price of CLP9.99 is trading 26.8% below its estimated GF Value™ of CLP13.64. GuruFocus considers Essbio to be Modestly Undervalued.

Key valuation signals for XSGO:ESSBIO-C:

  • Other Current Receivables: CLP4,022 Mil
  • GF Value™: CLP13.64 vs. price of CLP9.99 (26.8% below fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the XSGO:ESSBIO-C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Essbio Business Description

Address Prat Avenue 199 Tower B, 15th floor, Concepcion, CHL
Essbio SA is a water utility company in Chile. The company is engaged in the production and distribution of drinking water; evacuation and decontamination of sewage and industrial wastewater treatment and technical assistance to rural water systems. It provides Provide high-quality solutions and services in the integral water cycle (potable water, sewage, and decontamination of wastewater) and in the integral management of waste.
60GF Score

Get the complete analysis for XSGO:ESSBIO-C

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CLP9.99
Price
CLP13.64
GF Value